Results 211 to 220 of about 236,531 (317)

Low Testosterone in Men With Type 2 Diabetes: The Role of Estrogen Excess and Aromatase Activity

Clinical Endocrinology, Volume 104, Issue 4, Page 362-371, April 2026.
ABSTRACT Objective Low testosterone is common in men with type 2 diabetes and is associated with adverse metabolic outcomes. Our objective was to identify factors associated with low total and calculated free testosterone (CFT) in men with type 2 diabetes, with a focus on relative estrogen excess and subcutaneous adipose aromatase expression.
Nyo Nyo Z. Tun, Dawn E. W. Livingstone, Fraser W. Gibb   +2 more
wiley   +1 more source

Combined HMG/HCG treatment in subfertile men with idiopathic normogonadotropic ogliozoospermia [PDF]

, 1982
Braun, S., Jüngst, Dieter, Schill, W. B., Unterburger, P.   +3 more
core  

Testosterone Replacement Therapy in Men Aged 50 and Above: A Narrative Review of Evidence-Based Benefits, Safety Considerations, and Clinical Recommendations. [PDF]

Cureus
Canal de Velasco LM, González Flores JE, Morales Arteaga JL.   +2 more
europepmc   +1 more source

Mitochondrial DNA Depletion Syndrome 1 (MTDPS1)—A Novel Cause of Premature Ovarian Insufficiency

Clinical Genetics, Volume 109, Issue 4, Page 784-787, April 2026.
We describe a woman with MNGIE due to a novel homozygous TYMP nonsense variant and propose MNGIE as the cause of her premature ovarian insufficiency—a rarely reported association—highlighting the need to consider mitochondrial disease in unexplained POI, especially in atypical, consanguineous presentations. ABSTRACT Mitochondrial DNA depletion syndrome
Michael Matheou, Helen Turner, Deborah Shears, Fredrik Karpe   +3 more
wiley   +1 more source

Clinical Predictors of Response to Testosterone Replacement Therapy in Boys With Micropenis: A Retrospective Study Focusing on Penile Morphology and Hormonal Factors. [PDF]

Int J Urol
Harada J, Mitsunari K, Kakita S, Fukushima H, Kawamura H, Kurata H, Matsuda T, Motokawa M, Ito I, Araki K, Nakamura Y, Matsuo T, Dateki S, Kihara T, Ohba K, Mochizuki Y, Imamura R.   +16 more
europepmc   +1 more source

Endogenous oestrogens as neuroprotective modulators in the human retina: Evidence from transcriptomic profiling and aromatase inhibition

Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Single‐cell transcriptomics reveals that the human retina expresses a broad repertoire of steroid hormone biosynthesis and estrogen signalling genes. Functional validation in retinal explants shows that local estrogen synthesis is neuroprotective, preventing photoreceptor death and limiting microglial activation. Abstract Steroid hormones, particularly
Antolin Canto, Javier Valero‐Ochando, Rosa López‐Pedrajas, Teresa Olivar, Vicente Hernández‐Rabaza, Inmaculada Almansa, María Miranda   +6 more
wiley   +1 more source

Testosterone Replacement Therapy in Hypogonadal Men with a Prostate Cancer Diagnosis: A British Society for Sexual Medicine Consensus Statement. [PDF]

World J Mens Health
Edison MA, Kirby M, Hackett GI.
europepmc   +1 more source

Report of the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) on nutritional risks for women during menopause, perimenopause and postmenopause

Food Risk Assess Europe, Volume 4, Issue 2, April 2026.
Abstract Menopause is the time when a woman transitions from the reproductive stage of life to the non‐reproductive state. It is characterised by significant hormonal changes, which can affect a woman's physical, emotional, mental and social well‐being.
Irene Bretón Lesmes, Concepción María Aguilera García, Araceli Díaz Perales, Ángel Gil Izquierdo, Gema Nieto Martínez, Ana María Rivas Velasco, Virginia Arianna Aparicio García‐Molina, María Ángeles Carlos Chillerón   +7 more
wiley   +1 more source

Testosterone Replacement Therapy Is Not Associated with Greater Revision Rates in Reverse Total Shoulder Arthroplasty. [PDF]

J Clin Med
Parmar RP, Cronen A, Hui C, Stickels M, Lederman E, Shah A.   +5 more
europepmc   +1 more source

Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing Radiotherapy. [PDF]

Cureus
Shigehara K, Naito R, Kawahara T, Kato Y, Shinzawa R, Yaegshi H, Nohara T, Izumi K, Mizokami A.   +8 more
europepmc   +1 more source